Co-Authors
This is a "connection" page, showing publications co-authored by Nishant Agrawal and Zhen Gooi.
Connection Strength
2.433
-
Tonsil Cancer. N Engl J Med. 2019 Jul 25; 381(4):e8.
Score: 0.739
-
Lip and Oral Cavity Squamous Cell Carcinoma. Hematol Oncol Clin North Am. 2021 10; 35(5):895-911.
Score: 0.212
-
Head and Neck Masses. Med Clin North Am. 2018 Nov; 102(6):1013-1025.
Score: 0.174
-
Role of dental hardware in oral cavity squamous cell carcinoma in the low-risk nonsmoker nondrinker population. Head Neck. 2018 04; 40(4):784-792.
Score: 0.167
-
AHNS Series - Do you know your guidelines? Principles of treatment for glottic cancer: A review of the National Comprehensive Cancer Network guidelines. Head Neck. 2017 09; 39(9):1729-1732.
Score: 0.160
-
Risk of thyroid malignancy following an index head and neck squamous cell carcinoma: A population-based study. Ear Nose Throat J. 2016 Dec; 95(12):E7-E11.
Score: 0.154
-
AHNS Series - Do you know your guidelines? Principles of treatment for nasopharyngeal cancer: A review of the National Comprehensive Cancer Network guidelines. Head Neck. 2017 02; 39(2):201-205.
Score: 0.154
-
Risk of second primary malignancy after nasopharyngeal carcinoma in the United States: A population-based study. Head Neck. 2016 04; 38 Suppl 1:E1130-6.
Score: 0.141
-
Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke. Head Neck. 2015 Nov; 37(11):1642-9.
Score: 0.131
-
Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma. Br J Cancer. 2022 11; 127(8):1497-1506.
Score: 0.057
-
Characterizing Lymph Node Burden With Elective Unilateral Neck Irradiation in Human Papillomavirus-Positive Tonsil Squamous Cell Carcinoma: Defining the Upper Limits. Cureus. 2022 Jul; 14(7):e27521.
Score: 0.057
-
Molecular drivers of oral cavity squamous cell carcinoma in non-smoking and non-drinking patients: what do we know so far? Oncol Rev. 2022 Feb 22; 16(1):549.
Score: 0.055
-
Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment. BMC Cancer. 2022 Jan 03; 22(1):17.
Score: 0.055
-
Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience. Oral Oncol. 2021 11; 122:105566.
Score: 0.054
-
Dose and Volume De-Escalation for Human Papillomavirus-Positive Oropharyngeal Cancer is Associated with Favorable Posttreatment Functional Outcomes. Int J Radiat Oncol Biol Phys. 2020 07 15; 107(4):662-671.
Score: 0.049
-
Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience. Oral Oncol. 2018 05; 80:16-22.
Score: 0.042
-
Human papillomavirus status of head and neck cancer as determined in cytologic specimens using the hybrid-capture 2 assay. Oral Oncol. 2014 Jun; 50(6):600-4.
Score: 0.032